releases: https://www.toomey.senate.gov/newsroom/press-releases/advisory-toomey-and-stabenow-to-lead-senate-hearing-examining-the-alzheimers-crisis
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.toomey.senate.gov/newsroom/press-releases/advisory-toomey-and-stabenow-to-lead-senate-hearing-examining-the-alzheimers-crisis | Advisory: Toomey and Stabenow to Lead Senate Hearing Examining the Alzheimers Crisis | 2020-12-15 | 2020 | 2020-12 | Republican | House | PA | Patrick Toomey | T000461 | www.toomey.senate.gov | legacy | Washington, D.C. U.S. Senator Pat Toomey (R-Pa.), the chairman of the Senate Finance Committee Subcommittee on Health Care, will convene a hearing examining the testing and treatment for Alzheimer's disease and the fiscal implications of the disease on our federal healthcare programs onWednesday, December 16that 2:30 PM. Last year, the Senate Finance Committee Subcommittee on Health Care held a hearing on thebarriers to treatment and care for Alzheimer's patients. Chairman Toomey and Ranking Member Debbie Stabenow (D-Mich.)also sought inputfrom stakeholdersproviders, researchers, patients, patient advocacy groups, states, and othersto inform the development of regulatory recommendations and potential future legislation. The senatorssent a letter to the Administrationin October, requesting certain regulatory actions to improve care for Alzheimer's patients. What:Hearing: The Alzheimer's Crisis: Examining Testing and Treatment Pipelines and Fiscal Implications. When:Wednesday, December 16that 2:30 PM. Witnesses: Nikolay Dokholyan, Ph.D., M.S. G. Thomas Passananti, Professor and Vice Chair for Research Pennsylvania State College of Medicine, Hershey, Pa. Randall J. Bateman, M.D. Charles F. and Joanne Knight Distinguished Professor of Neurology, Director, Dominantly Inherited Alzheimer's Network (DIAN), DIAN Trials Unit Washington University School of Medicine, St. Louis, Mo. Richard Mohs, Ph.D. Chief Scientific Officer Global Alzheimer's Platform Foundation, Chicago, Ill. Maria Carrillo, Ph.D. Chief Science Officer Alzheimer's Association, Chicago, Ill. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |